[HTML][HTML] COVID-19, renin-angiotensin system and endothelial dysfunction
R Amraei, N Rahimi - Cells, 2020 - mdpi.com
The newly emergent novel coronavirus disease 2019 (COVID-19) outbreak, which is caused
by SARS-CoV-2 virus, has posed a serious threat to global public health and caused …
by SARS-CoV-2 virus, has posed a serious threat to global public health and caused …
Low serum albumin: a neglected predictor in patients with cardiovascular disease
AA Manolis, TA Manolis, H Melita, DP Mikhailidis… - European Journal of …, 2022 - Elsevier
Albumin, the most abundant circulating protein in blood, is an essential protein which binds
and transports various drugs and substances, maintains the oncotic pressure of blood and …
and transports various drugs and substances, maintains the oncotic pressure of blood and …
Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases
CG Schalkwijk, CDA Stehouwer - Physiological reviews, 2020 - journals.physiology.org
The formation and accumulation of methylglyoxal (MGO), a highly reactive dicarbonyl
compound, has been implicated in the pathogenesis of type 2 diabetes, vascular …
compound, has been implicated in the pathogenesis of type 2 diabetes, vascular …
Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
CP Domingueti, LMSA Dusse… - Journal of Diabetes and …, 2016 - Elsevier
Background Vascular complications are the leading cause of morbidity and mortality among
patients with type 1 and type 2 diabetes mellitus. These vascular abnormalities result of a …
patients with type 1 and type 2 diabetes mellitus. These vascular abnormalities result of a …
[HTML][HTML] Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches
Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney
disease (CKD). Both conditions are rising in incidence as well as prevalence, creating poor …
disease (CKD). Both conditions are rising in incidence as well as prevalence, creating poor …
Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences
CDA Stehouwer - Diabetes, 2018 - Am Diabetes Assoc
Microvascular and metabolic physiology are tightly linked. This Perspective reviews
evidence that 1) the relationship between hyperglycemia and microvascular dysfunction …
evidence that 1) the relationship between hyperglycemia and microvascular dysfunction …
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular …
Chronic kidney disease1 (CKD) is a worldwide public health problem. In the United States,
there is a rising incidence and prevalence of kidney failure, with poor outcomes and high …
there is a rising incidence and prevalence of kidney failure, with poor outcomes and high …
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen… - Jama, 2001 - jamanetwork.com
ContextMicroalbuminuria is a risk factor for cardiovascular (CV) events. The relationship
between the degree of albuminuria and CV risk is unclear. ObjectivesTo estimate the risk of …
between the degree of albuminuria and CV risk is unclear. ObjectivesTo estimate the risk of …
Endothelial dysfunction
DH Endemann, EL Schiffrin - Journal of the American Society of …, 2004 - journals.lww.com
Endothelial dysfunction is characterized by a shift of the actions of the endothelium toward
reduced vasodilation, a proinflammatory state, and prothrombic properties. It is associated …
reduced vasodilation, a proinflammatory state, and prothrombic properties. It is associated …
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
AM Schmidt, SD Yan, JL Wautier, D Stern - Circulation research, 1999 - Am Heart Assoc
Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin
superfamily of cell surface molecules and engages diverse ligands relevant to distinct …
superfamily of cell surface molecules and engages diverse ligands relevant to distinct …